Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Released May 21, 2012, after the close
10-Q filed May 21, 2012, 51 days after period end · 0001424884-12-000038
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Net Income | -$598.57K | -$1.27M |
| EPS Diluted | -$0.01 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 21, 2012 · 51 d after period end
